» Articles » PMID: 25354866

Histological Validation of Cardiac Magnetic Resonance Analysis of Regional and Diffuse Interstitial Myocardial Fibrosis

Overview
Date 2014 Oct 31
PMID 25354866
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Myocardial fibrosis is fundamental in the pathogenesis of heart failure. Late gadolinium enhancement (LGE) with cardiac magnetic resonance (CMR) imaging is commonly assumed to represent myocardial fibrosis; however, comparative human histological data are limited, especially in non-ischaemic cardiac disease. Diffuse interstitial myocardial fibrosis is increasingly recognized as central in the pathogenesis of cardiomyopathy and can be quantified using newer CMR techniques such as T1 mapping. We evaluated the relationship of CMR assessment of regional and diffuse fibrosis with human histology.

Methods And Results: Eleven patients on the waiting list for heart transplantation (43.5 ± 7.6 years, 64% male) and eight patients undergoing surgical myectomy for obstructive hypertrophic cardiomyopathy (57.1 ± 8.6 years, 63% male) were recruited and underwent CMR prior to cardiac transplantation or myectomy. Quantification of fibrosis in explanted hearts using digitally analysed Masson-trichrome-stained slides was validated against picrosirius red-stained slides analysed using Image J, with an excellent correlation (R = 0.95, P < 0.0001). Significant correlations were observed between LGE and histological fibrosis across a range of signal intensity thresholds in the explanted hearts (range: 2-10 standard deviations above reference myocardium), with maximal accuracy at a threshold of 6 SD (R = 0.91, P < 0.001). Assessment of interstitial myocardial fibrosis with post-contrast T1 times demonstrated a significant correlation on both segmental (R = -0.64, P = 0.002) and per-patient (R = -0.78, P = 0.003) analyses.

Conclusion: CMR provides accurate, non-invasive assessment of regional myocardial fibrosis using LGE, while diffuse interstitial myocardial fibrosis is accurately assessed with post-contrast T1 mapping.

Citing Articles

Predictors of Improvement in Left Ventricular Systolic Dysfunction in Patients with Atrial Fibrillation Undergoing Catheter Ablation: Systematic Review.

Ahluwalia N, Hussain A, Providencia R, Schilling R Arrhythm Electrophysiol Rev. 2025; 14:e02.

PMID: 40017669 PMC: 11865674. DOI: 10.15420/aer.2024.24.


The influence of HIV infection on myocardial fibrosis diagnosed by cardiac magnetic resonance imaging in adults: a systematic review and meta-analysis of observation studies.

Mutengo K, Lima B, Mutale W, Mweemba A, Kabwe L, Banda C Front Cardiovasc Med. 2025; 12:1534533.

PMID: 39944603 PMC: 11814457. DOI: 10.3389/fcvm.2025.1534533.


CMR assessment of epicardial edipose tissue in relation to myocardial inflammation and fibrosis in patients with new-onset atrial arrhythmias after STEMI.

Ren Y, Du X, Li M, Chen L, Liu J, Wu Y BMC Cardiovasc Disord. 2025; 25(1):34.

PMID: 39833688 PMC: 11748530. DOI: 10.1186/s12872-025-04486-1.


Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?.

Chumakova O, Mershina E Exp Biol Med (Maywood). 2025; 249():10334.

PMID: 39744621 PMC: 11688189. DOI: 10.3389/ebm.2024.10334.


Late Enhancement Computed Tomography for Left Atrial Fibrosis Imaging: A Pilot "Proof-of-Concept" Study.

Lacaita P, Beyer C, Plank F, Stuhlinger M, Feuchtner G Diagnostics (Basel). 2024; 14(23).

PMID: 39682660 PMC: 11640274. DOI: 10.3390/diagnostics14232753.